However, treatment of tumor burden mice injected with FOSL2-overexpressing NFs using BOX5 (Wnt5a antagonist) mitigated FOSL2-stimulated blood vessels and tumor growth (Figure 8B-C and Figure S6C). The gene discussed is FOSL2; the disease is neoplasm.